Physician profile
Nicholas Tan
NPI 1770962029
$21,054.05
in general payments reported to CMS, 2019-2025
6 companies · $3,758 in 2025
The $3,758 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $388 · 2022: $9,805 · 2023: $4,726 · 2024: $2,376 · 2025: $3,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,024 · Food and Beverage: $2,192 · Grant: $1,500 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,024.30 |
| Food and Beverage | $2,192.20 |
| Grant | $1,500.00 |
| Education | $144.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,539.96 | 2022-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Affera Mapping System |
| Abbott Laboratories | $4,588.71 | 2021-2025 | Aveir, Na, Ensite |
| Biotronik INC. | $1,491.64 | 2021-2023 | Edora 8 Dr-T, Acticor 7 Vr-T Dx, Solia |
| Atricure, INC. | $788.98 | 2022-2025 | Epi-Ease Epicardial Access System |
| Boston Scientific Corporation | $598.16 | 2022 | |
| Philips North America LLC | $46.60 | 2023 | (9520) Igt Devices Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.